Skip to main content
. Author manuscript; available in PMC: 2015 Jan 3.
Published in final edited form as: Vaccine. 2013 Nov 17;32(2):258–264. doi: 10.1016/j.vaccine.2013.11.016

Table 2.

Analytes associated with inflammation or tissue damage with a four-fold or greater change in concentration as a result of JEV SA14-14-2 infection in AG129 mice.

Serum Brain Spleen
Pro-inflammatory
CRP C-Reactive Protein Mouse
CD40 CD40
CD40L CD40 Ligand
Fibrinogen
GM-CSF Granulocyte-Macrophage Colony Stimulating Factor
KC/GRO Growth-Regulated Alpha Protein
IFNγ Interferon gamma
IP-10 Interferon gamma induced protein
IL-1α Interleukin-1 alpha
IL-1β Interleukin-1 beta
IL-6 Interleukin-6
IL-11 Interleukin-11
IL-12p70 Interleukin-12 subunit p70
IL-18 Interleukin 18
MDC Macrophage-derived chemokine
MIP-1 α Macrophage Inflammatory protein-1 alpha
MIP-1 β Macrophage Inflammatory protein-1 beta
MIP-1 γ Macrophage Inflammatory protein-1 gamma
MIP-2 Macrophage inflammatory protein-2
MIP-3β Macrophage inflammatory protein 3 beta
MCP-1 Monocyte chemotactic protein-1
MCP-3 Monocyte chemotactic protein-3
MCP-5 Monocyte chemotactic protein-5
OSM Oncostatin-M
RANTES T-cell Specific Protein RANTES
TNFα Tumor Necrosis Factor alpha

Anti-inflammatory
IL-10 Interleukin-10
TMP-1 Tissue Inhibitor of Metalloproteinases

Tissue damage
IL-7 Interleukin-7
MMP-9 Matrix Metalloproteinase-9
MPO Myeloperoxidase
Myoglobin
PAI-1 Plasminogen Activator Inhibitor-1